Mr. Conroy is the Chief Executive Officer (CEO) of ARTMS Products. Mr. Conroy brings to ARTMS more than 25 years of experience in the life sciences industry, including several significant senior positions within the radiopharmaceutical industry. Most recently Mr. Conroy was the General Manager of Jubilant Pharma where he was responsible for North American sales and operations. Prior to joining Jubilant, he was the Chief Operating Officer of PharmBlue LLC, a nationwide specialty pharmacy business focusing on the federal 340B drug program, retroviruses, mental and behavioral health, custom compounding, and pain management.
Previously, he was the Senior Director of Pharmacy Operations managing Express Scripts’ flagship pharmacy at the Technology and Innovation Center in St. Louis, Missouri. In that capacity, Mr. Conroy was responsible for launching the latest technology and refining operational processes to ensure that over 40 million prescriptions were filled annually. For his efforts, he was given the Chairman’s Award, a distinction given to only a handful of top performers. While at Express Scripts, Mr. Conroy also led UBC’s Patient Assistance Programs and Call Centers operations in St Louis, overseeing 1,200 clinical, clerical and administrative personnel who served over 50 different Pharma corporations.
Mr. Conroy has held a variety of roles with increasing responsibility at Amerinet (Intalere), Covidien, Eli Lilly and Nycomed Amersham (GE Healthcare).
Mr. Conroy earned a Bachelors in Science, Pharmacy from Purdue University and a Masters of Business Administration from the University of Michigan. Mr. Conroy was among the first to earn his Board Certification in Nuclear Pharmacy (BCNP) and is a registered pharmacist in 17 states.